DelveInsight’s Neurovascular Devices Market Insights Report 2034 provides the current and forecast market analysis, individual leading Neurovascular Devices Companies market shares, challenges, Neurovascular Devices Market Drivers, barriers, trends, and key market Neurovascular Devices companies in the market.
To read more about the latest highlights related to the Neurovascular Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
Key Takeaways from the Neurovascular Devices Market Report
- In May 2025, Terumo Interventional Systems announced the commercial launch of its FDA-approved ROADSAVER™ Carotid Stent System, designed for use with the Nanoparasol® Embolic Protection System for the treatment of carotid artery stenosis in patients at elevated risk of complications from carotid endarterectomy.
- In April 2025, Terumo Neuro’s Dual-Layer Micromesh Carotid Stent System received FDA Premarket Approval (PMA), becoming the first of its kind in the U.S., targeting carotid stenosis including both de novo and post-endarterectomy restenotic lesions.
- The Global Neurovascular Devices Market Size is expected to increase from USD 3,904.74 million in 2025 to USD 8,044.66 million by 2034, growing at a CAGR of 8.40% during the forecast period from 2026 to 2034.
- The leading Neurovascular Devices Companies include Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others.
- North America is projected to hold the largest share of approximately 38% of the Neurovascular Devices market in 2025, driven by the high prevalence of stroke and other neurovascular disorders, a well-established healthcare infrastructure, strong adoption of advanced minimally invasive technologies, and supportive reimbursement policies.
To know more about why North America is leading the market growth in the Neurovascular Devices Market, get a snapshot @ Neurovascular Devices Market Outlook
Neurovascular Devices Market Dynamics
The Neurovascular Devices Market is being primarily driven by the rising prevalence of neurological disorders such as stroke, cerebral aneurysms, arteriovenous malformations, and other cerebrovascular diseases. According to DelveInsight analysis, the 7MM (United States, Japan, Germany, France, Italy, Spain, and the United Kingdom) accounted for over 1.5 million cases of acute ischemic stroke, while globally more than 3.5 million new cases of intracerebral hemorrhagic stroke occur each year, representing over 28.5% of all stroke incidents. Approximately 1.3 million new subarachnoid hemorrhagic strokes are reported annually, with over 23.1% of intracerebral hemorrhagic strokes and 28% of subarachnoid hemorrhagic strokes affecting individuals aged 15–49. Growing awareness about early diagnosis, advancements in minimally invasive procedures, AI-powered imaging systems, and improved healthcare infrastructure are further accelerating the adoption of neurovascular devices across hospitals and specialty neurology centers globally.
Get a sneak peek at the Neurovascular Devices Market Dynamics @ Neurovascular Devices Market Dynamics Analysis
Neurovascular Devices Market Segmentation Analysis
Neurovascular Devices Market by Product Type (Cerebral Embolization and Aneurysm Coiling Devices [Embolic Coils, Flow Diversion Devices, and Liquid Embolic Agents], Cerebral Balloon Angioplasty and Stenting Systems [Carotid Artery Stents and Embolic Protection Systems], Neurothrombectomy Devices [Clot Retrievers, Suction Devices, and Vascular Snare], and Support Devices [Micro Catheters and Micro Guidewires]), Application (Stroke, Cerebral Aneurysm, Carotid Artery Stenosis, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Neurovascular Devices Companies
Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others.
Neurovascular Devices Market Drivers
The demand for neurovascular devices is being driven by several key factors, including the rising incidence of ischemic and hemorrhagic strokes, cerebral aneurysms, and arteriovenous malformations, particularly among the aging population and individuals with risk factors such as hypertension and diabetes. Continuous technological advancements in next-generation stent retrievers, flow diverters, embolic coils, AI-enabled imaging systems, and robotic-assisted interventional tools are enhancing procedural precision, safety, and success rates while reducing recovery times. Increasing product development activities among key market players, growing awareness programs for stroke prevention, and expanding healthcare infrastructure across emerging markets are further creating a supportive environment for sustained market growth. These trends are expected to position the neurovascular devices market for robust and steady expansion from 2026 to 2034.
Which MedTech key players in the Neurovascular Devices Market are set to emerge as the trendsetter? Explore @ Neurovascular Devices Companies
Scope of the Neurovascular Devices Market Report
- Coverage: Global
- Study Period: 2023 to 2034
- Forecast Period: 2026 to 2034
- Neurovascular Devices Companies: Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others.
Interested in knowing the Neurovascular Devices Market by 2034? Click to get a snapshot of the Neurovascular Devices Market Trends
Table of Contents
- Neurovascular Devices Market Report Introduction
- Neurovascular Devices Market Executive Summary
- Neurovascular Devices Market Key Factors Analysis
- Impact Analysis
- Regulatory Analysis
- Neurovascular Devices Market Porter’s Five Forces Analysis
- Neurovascular Devices Market Assessment
- Competitive Landscape
- Startup Funding & Investment Trends
- Neurovascular Devices Market Company and Product Profiles
- Neurovascular Devices KOL Views
- Project Approach
- About DelveInsight
- Disclaimer & Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk
